A phase 3 program enrolling adults with overweight or obesity is slated to start in the first quarter of 2026. In January, Novo recorded 22% weight loss in people who received weekly amycretin ...

Novo Nordisk stock is down 5.5% YTD and 43% over the past year. Live on Wednesday June 18: 3 Summer "Power Patterns" Are About to Trigger (One With 90% Win Rate). See Them Here. Novo Nordisk A/S ...

Bagsværd, Denmark, 12 June 2025 – Novo Nordisk today announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical studies.

but Novo Nordisk is trying to change that. The Danish drugmaker has reported the first phase 3 results with its new basal insulin product – insulin icodec – which backs up earlier data ...

The Federal Emergency Management Agency (FEMA) says residents should assemble a basic disaster supplies kit that will last every family member, including pets, for at least a week. Hurricane ...

Five beaver kits have been born in Cairngorms National Park for the second year in a row – after a 400-year hiatus. The kits have been captured on camera at two separate sites in the park ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.

Forbes contributors publish independent expert analyses and insights. Tima Bansal is an award-winning professor of strategy.

Tester Heather Riesebeck took 1 gummy every day for 3 weeks and reported feeling the effects about 45 minutes afterward. She was particularly impressed by the flavor of the Peach option.